Insider Transactions in Q1 2022 at Sleep Number Corp (SNBR)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
45,178
+17.78%
|
-
|
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
45,178
-33.92%
|
-
|
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,871
-22.14%
|
$2,082,905
$55.54 P/Share
|
|
Mar 29
2022
|
Shelly Radue Ibach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,049
+32.68%
|
-
|
|
Mar 29
2022
|
Melissa Barra EVP, Chief Sales & Services |
SELL
Payment of exercise price or tax liability
|
Direct |
4,568
-8.25%
|
$251,240
$55.54 P/Share
|
|
Mar 29
2022
|
Melissa Barra EVP, Chief Sales & Services |
BUY
Grant, award, or other acquisition
|
Direct |
14,070
+20.27%
|
-
|
|
Mar 29
2022
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,594
-7.71%
|
$362,670
$55.54 P/Share
|
|
Mar 29
2022
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,402
+13.55%
|
-
|
|
Mar 29
2022
|
Kevin Kennedy Brown EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,933
-13.25%
|
$326,315
$55.54 P/Share
|
|
Mar 29
2022
|
Kevin Kennedy Brown EVP and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
12,057
+21.21%
|
-
|
|
Mar 29
2022
|
David R Callen EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,923
-13.37%
|
$380,765
$55.54 P/Share
|
|
Mar 29
2022
|
David R Callen EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,070
+21.37%
|
-
|
|
Mar 29
2022
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,847
-24.73%
|
$266,585
$55.54 P/Share
|
|
Mar 29
2022
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,383
+32.38%
|
$45,479,401
$4847.0 P/Share
|
|
Mar 29
2022
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,213
-12.53%
|
$66,715
$55.54 P/Share
|
|
Mar 29
2022
|
Christopher D Krusmark EVP & Chief H.R. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,240
+18.79%
|
-
|
|
Mar 29
2022
|
Joseph Hunter Saklad EVP, Chief Supply Chain Office |
SELL
Payment of exercise price or tax liability
|
Direct |
2,872
-5.67%
|
$157,960
$55.54 P/Share
|
|
Mar 29
2022
|
Joseph Hunter Saklad EVP, Chief Supply Chain Office |
BUY
Grant, award, or other acquisition
|
Direct |
9,383
+15.63%
|
-
|
|
Mar 29
2022
|
Robert Joseph Poirier VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
874
-24.12%
|
$48,070
$55.54 P/Share
|
|
Mar 29
2022
|
Robert Joseph Poirier VP, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,613
+30.8%
|
-
|
|
Mar 21
2022
|
David R Callen EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,117
-13.96%
|
$373,137
$61.98 P/Share
|
|
Mar 15
2022
|
Robert Joseph Poirier VP, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-3.13%
|
$3,965
$61.66 P/Share
|
|
Mar 15
2022
|
Kevin Kennedy Brown EVP and CMO |
SELL
Discretionary transaction
|
Indirect |
3
-0.45%
|
$189
$63.47 P/Share
|
|
Mar 15
2022
|
David R Callen EVP & CFO |
SELL
Discretionary transaction
|
Indirect |
18
-0.61%
|
$1,134
$63.47 P/Share
|
|
Mar 15
2022
|
Samuel R Hellfeld EVP Chief Legal & Risk Officer |
SELL
Discretionary transaction
|
Indirect |
21
-0.49%
|
$1,323
$63.47 P/Share
|
|
Mar 15
2022
|
Shelly Radue Ibach President and CEO |
SELL
Discretionary transaction
|
Indirect |
19
-0.12%
|
$1,197
$63.47 P/Share
|
|
Mar 15
2022
|
Christopher D Krusmark EVP & Chief H.R. Officer |
SELL
Discretionary transaction
|
Indirect |
3
-0.23%
|
$189
$63.47 P/Share
|
|
Mar 10
2022
|
Daniel Alegre Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+2.69%
|
$21,018
$62.55 P/Share
|
|
Mar 10
2022
|
Deborah L. Kilpatrick Director |
BUY
Bona fide gift
|
Indirect |
339
+2.97%
|
-
|
|
Mar 10
2022
|
Deborah L. Kilpatrick Director |
SELL
Bona fide gift
|
Direct |
339
-29.25%
|
-
|
|
Mar 10
2022
|
Deborah L. Kilpatrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+22.63%
|
$21,018
$62.55 P/Share
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
BUY
Bona fide gift
|
Indirect |
6,000
+3.54%
|
-
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
SELL
Bona fide gift
|
Direct |
6,000
-6.38%
|
-
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,120
-11.42%
|
$751,440
$62.2 P/Share
|
|
Mar 01
2022
|
Shelly Radue Ibach President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,120
+8.17%
|
$471,120
$26.07 P/Share
|
|
Feb 25
2022
|
Brenda J Lauderback Director |
SELL
Open market or private sale
|
Direct |
1,660
-4.51%
|
$104,580
$63.35 P/Share
|
|
Feb 25
2022
|
Brenda J Lauderback Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,499
+6.35%
|
$67,473
$27.45 P/Share
|
|
Feb 25
2022
|
Daniel Alegre Director |
SELL
Open market or private sale
|
Direct |
17,000
-58.8%
|
$1,105,000
$65.89 P/Share
|
|
Feb 25
2022
|
Stephen L Gulis Jr Director |
SELL
Bona fide gift
|
Direct |
950
-3.44%
|
-
|
|
Jan 13
2022
|
Andrea Lee Bloomquist EVP, Chief Innovation Officer |
BUY
Acquisition or disposition by will or laws
|
Indirect |
603
+50.0%
|
-
|